Cargando…
Finding good biomarkers for sarcopenia
The term sarcopenia describes the age-related loss of skeletal muscle mass and function. While this process, in principal, occurs in every adult person and already starts around the age of 40, it is associated with disability, morbidity, and increased mortality in some individuals. In the absence of...
Autores principales: | Scharf, Gesine, Heineke, Joerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424189/ https://www.ncbi.nlm.nih.gov/pubmed/22911244 http://dx.doi.org/10.1007/s13539-012-0081-7 |
Ejemplares similares
-
TNF-α signaling: TACE inhibition to put out the burning heart
por: Dittrich, Gesine M., et al.
Publicado: (2020) -
Hospital‐associated sarcopenia, acute sarcopenia, and iatrogenic sarcopenia: Prevention of sarcopenia during hospitalization
por: Wakabayashi, Hidetaka
Publicado: (2023) -
Sarcopenia: 2020
por: Morley, John E.
Publicado: (2021) -
Sarcopenia and the Brain
Publicado: (2021) -
Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
por: Oh, Sooyeon, et al.
Publicado: (2020)